Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Schizophrenia

Free Subscription 03.02.2020 1 Acta Psychiatr Scand 1 Cortex 1 J Clin Psychiatry 1 J Clin Psychopharmacol 1 J Int Neuropsychol Soc 1 Neuropsychopharmacology 1 Pharmacopsychiatry 2 Psychiatry Res 1 Psychol Med 6 Schizophr Res 1 Science

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Psychiatr Scand

1. JONES R, MacCabe JH, Price MJ, Xiangxin L, et al
   Effect of age on the relative efficacy of clozapine in schizophrenia.
   Acta Psychiatr Scand. 2020 Jan 24. doi: 10.1111/acps.13156.
   PubMed     Text format     Abstract available
   
   

   
   Cortex

2. THUAIRE F, Rondepierre F, Bacon E, Vallet GT, et al
   Executive functions in schizophrenia aging: Differential effects of age within specific executive functions.
   Cortex. 2019;125:109-121.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Psychiatry

3. MCEVOY JP, Kremens DE
   Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
   J Clin Psychiatry. 2020;81.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Psychopharmacol

4. MIURA G, Misawa F, Kawade Y, Fujii Y, et al
   Long-Acting Injectables Versus Oral Antipsychotics: A Retrospective Bidirectional Mirror-Image Study.
   J Clin Psychopharmacol. 2019;39:441-445.
   PubMed     Text format     Abstract available
   
   

   
   J Int Neuropsychol Soc

5. CASTELLUCCIO BC, Kenney JG, Johannesen JK
   Individual Alpha Peak Frequency Moderates Transfer of Learning in Cognitive Remediation of Schizophrenia.
   J Int Neuropsychol Soc. 2020;26:19-30.
   PubMed     Text format     Abstract available
   
   

   
   Neuropsychopharmacology

6. TANI H, Takasu S, Uchida H, Suzuki T, et al
   Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
   Neuropsychopharmacology. 2020 Jan 23. pii: 10.1038/s41386-019-0598.
   PubMed     Text format     Abstract available
   
   

   
   Pharmacopsychiatry

7. KISHI T, Yoshimura R, Matsuda Y, Sakuma K, et al
   Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.
   Pharmacopsychiatry. 2020 Jan 30. doi: 10.1055/a-1096-1266.
   PubMed     Text format     Abstract available
   
   

   
   Psychiatry Res

8. F MIRSKY A
   Monte S. Buchsbaum and the Genain Quadruplets.
   Psychiatry Res. 2019;277:70-71.
   PubMed     Text format     Abstract available
   
   
9. SERRANO-GUERRERO E, Ruiz-Veguilla M, Martin-Rodriguez A, Rodriguez-Testal JF, et al
   Inflexibility of beliefs and jumping to conclusions in active schizophrenia.
   Psychiatry Res. 2020;284:112776.
   PubMed     Text format     Abstract available
   
   

   
   Psychol Med

10. O'NEILL A, Wilson R, Blest-Hopley G, Annibale L, et al
    Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
    Psychol Med. 2020 Jan 29:1-11. doi: 10.1017/S0033291719003519.
    PubMed     Text format     Abstract available
    
    

    
    Schizophr Res

11. BITANIHIRWE BKY, Woo TW
    A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis.
    Schizophr Res. 2020 Jan 27. pii: S0920-9964(19)30585.
    PubMed     Text format     Abstract available
    
    
12. HUO L, Zhang G, Du XD, Jia Q, et al
    The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia.
    Schizophr Res. 2020 Jan 24. pii: S0920-9964(19)30599.
    PubMed     Text format     Abstract available
    
    
13. PENNEY D, Joober R, Malla A, Lepage M, et al
    Understanding sex differences in cognitive insight across first-and-multiple episode psychosis.
    Schizophr Res. 2020 Jan 21. pii: S0920-9964(19)30594.
    PubMed     Text format     Abstract available
    
    
14. CLELLAND CL, Kantrowitz JT, Choo T, Clelland JD, et al
    Adjunctive sapropterin dihydrochloride treatment in schizophrenia: A positive proof-of-concept, rater-blind, randomized, multivitamin-controlled study.
    Schizophr Res. 2020 Jan 21. pii: S0920-9964(19)30609.
    PubMed     Text format    
    
    
15. CARRENO F, Helfer VE, Staudt KJ, Paese K, et al
    Quetiapine lipid core nanocapsules restore prepulse inhibition deficits in a neurodevelopmental model of schizophrenia in male and female rats.
    Schizophr Res. 2020 Jan 20. pii: S0920-9964(20)30024.
    PubMed     Text format     Abstract available
    
    
16. TASMIM S, Dada O, Wang KZ, Bani-Fatemi A, et al
    Early-life stressful events and suicide attempt in schizophrenia: Machine learning models.
    Schizophr Res. 2020 Jan 20. pii: S0920-9964(19)30568.
    PubMed     Text format     Abstract available
    
    

    
    Science

17. GULSUNER S, Stein DJ, Susser ES, Sibeko G, et al
    Genetics of schizophrenia in the South African Xhosa.
    Science. 2020;367:569-573.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: